Oncolys BioPharma (4588.TSE) Q4 2025 Earnings

7NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-31.65
-25.17
-18.69
-12.22

Details

Expected EPS
N/A
Actual EPS
-12.217423441600001
Surprise EPS
-12.22
Surprise Percent
+∞%

Description

Oncolys BioPharma (4588.TSE) has reported earnings of -12.217423441600001 per share for Q4 2025.

0 Comments

Share your thoughts